A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial

Peer Review reports

Original Submission
15 Aug 2019	Submitted	Original manuscript
11 Nov 2019	Reviewed	Reviewer Report - Jane Daniels
26 Nov 2019	Reviewed	Reviewer Report - Zhengping Liu
18 Dec 2019	Reviewed	Reviewer Report - Amy Charlotte Brenner
21 Dec 2019	Reviewed	Reviewer Report - Zainab Alimoradi
15 Mar 2020	Author responded	Author comments - Shaoying Yang
Resubmission - Version 2
15 Mar 2020	Submitted	Manuscript version 2
2 Apr 2020	Reviewed	Reviewer Report - Zhengping Liu
2 Apr 2020	Reviewed	Reviewer Report - Amy Charlotte Brenner
4 Apr 2020	Reviewed	Reviewer Report - Zainab Alimoradi
10 Apr 2020	Reviewed	Reviewer Report - Jane Daniels
13 Apr 2020	Reviewed	Reviewer Report - Kirsty Loudon
23 May 2020	Author responded	Author comments - Shaoying Yang
Resubmission - Version 3
23 May 2020	Submitted	Manuscript version 3
2 Jun 2020	Reviewed	Reviewer Report - Amy Charlotte Brenner
3 Jun 2020	Reviewed	Reviewer Report - Kirsty Loudon
1 Aug 2020	Author responded	Author comments - Shaoying Yang
Resubmission - Version 4
1 Aug 2020	Submitted	Manuscript version 4
Publishing
29 Aug 2020	Editorially accepted
9 Sep 2020	Article published	10.1186/s13063-020-04716-1

Back to article page